Bibliografía

American Diabetes Association. Standard of medical care in diabetes—2018. Diabetes Care. 2018;41 (Supplement 1):S1–S172.  [PubMed: 29222369]

Armstrong  DG, Coulton  AJM, Bus  SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367–75.  [PubMed: 28614678]

Bergenstal  RM, Gal  RL, Connor  CG  et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med. 2017;167:95–102.  [PubMed: 28605777]

Butalia  S, Palda  VA, Sargeant  RJ  et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299:806–13.  [PubMed: 18285592]

Centers for Disease Control and Prevention. National Diabetes Statistic Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017.

Chatterjee  S, Khunti  K, Davies  MJ. Type 2 diabetes. Lancet. 2017;389:2239–51.  [PubMed: 28190580]

Fayfman  M, Pasquel  FJ, Umpierrez  GE. Management of hyperglycemic crises. Med Clin North Am. 2017;101:587–606.  [PubMed: 28372715]

Holman  RR, Paul  SK, Bethel  A  et al. 10-year follow up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.  [PubMed: 18784090]

Inzucchi  SE. Diagnosis of diabetes. N Engl J Med. 2012;367:542–50.  [PubMed: 22873534]

Ismail-Beigi  F, Moghissi  E, Tiktin  M  et al. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554–9.  [PubMed: 21502652]

Kapoor  A, Page  S, LaValley  M  et al. Magnetic resonance imaging for diagnosing foot osteomyelitis. Arch Intern Med. 2007;167:125–32.  [PubMed: 17242312]

Lipska  KJ, Krumholz  H, Soones  T, Lee  SJ. A review of glycemic control in older adults with type 2 diabetes. JAMA. 2016;315:1034–45.  [PubMed: 26954412]

Lipsky  BA, Berendt  AR, Cornia  PB  et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:132–73.

The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 DM. N Engl J Med. 2008;358:2545–59.  [PubMed: 18539917]

The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.  [PubMed: 18539916]

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.  [PubMed: 8366922]

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 34) UK Prospective Diabetes Study Group. Lancet. 1998;352:837–53.  [PubMed: 9742976]

Valencia  WM, Florez  H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 2017;356:i6505.  [PubMed: 28096078]

Vinik  AI. Diabetic sensory and motor neuropathy. N Engl ...